Dragon Pharmaceutical Inactive 10-K2008 FY Annual report

Filed: 31 Mar 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: aban, abdominal, actu, agricultural, al, amoxicillin, antidilutive, arm, ascribed, Assignment, awaited, bout, boutique, busy, calendar, capped, catalog, catch, cavity, cefadroxil, cefminox, cefonicid, cefoperazone, cefoxitin, ceiling, Cephadroxil, children, chilled, Chin, circulation, citing, Classification, clearance, coli, compound, concurrently, confiscation, CONSOLIDATEDSTATEMENTSOFOPERATIONSAND, constitute, damage, deprecation, developme, deviate, divisional, Divison, don, dosage, ear, EmGH, emphasizing, employed, enlarge, enrolled, escrow, escrowed, eventually, Exhibit, expe, expenditure, facilitate, fast, fastest, flagship, Forschung, fragmentation, fragmented, friendly, genital, Germany, goal, gonorrhea, gonorrhoeae, Gradually, gram, horizontally, hub, hygiene, ical, Immunubiological, influenzae, inhibitor, inhibitory, injured, innovation, Island, Italian, Kosovo, leader, led, length, lessor, Levoflaxacin, live, ma, maceutical, match, mentioned, metropolitan, Mexico, mild, mix, mixed, movement, newly, notavailable, notification, nt, ofbankruptcy, ofDragon, opti, ormulation, overhaul, page, partial, partially, partic, petrochemical, phar, pneumonia, pneumoniae, Polymun, poor, powerhouse, pr, prescribed, pressure, printed, prod, promised, promissory, Pude, qualitative, quantitative, reaction, readily, realigned, realignment, refinanced, refurbishment, remote, resistance, resistant, rest, resumed, revocation, roduction, rural, SA, Sanyang, scheme, season, septicemia, shifting, Shipping, short, signature, similarly, slightly, spectrum, spend, strep, subcontractor, subsidized, subsidy, summer, suspending, terial, throat, Tier, Tongyong, township, traditional, tran, transparency, trend, unemployed, unfavorable, untapped, upstream, urban, urogenital, usage, variety, ve, version, vertically, vitamin, wealthier

Removed: achieved, alternative, assistance, assume, biotechnology, called, commencement, controlled, dominated, employment, energy, enter, event, evolve, expensive, favor, fluctuation, fulfilled, hold, hospital, import, intention, iv, largely, letter, liable, obtaining, organization, prescription, proposed, proprietary, repaid, selection, sheet, shortage, space, survey, type, upgrade

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Dragon Pharmaceutical similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF
TITLE 18, UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of Dragon Pharmaceutical Inc., a Florida corporation (the “Company”), does hereby certify with respect to the Annual Report of the Company on Form 10-K for the year ended December 31, 2008 as filed with the Securities and Exchange Commission (the “Form 10-K”) that, to the best of their knowledge:

(1) the Form 10-K fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: : March 30, 2009		/s/ Yanlin Han
		Yanlin Han Chairman and Chief Executive Officer

Dated: : March 30, 2009		/s/ Garry Wong
		Garry Wong Chief Financial Officer